A director of Immunome, Inc. sold company stock on July 2, 2026, disclosing the transaction to the SEC.
10 reports, 2 independent
Updated Tue 00:00
Mostly repetition
Reached 2 outlets in its first 24 hours
- Reports
- 10
- Developments
- 2
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A director of Immunome, Inc. sold company stock on July 2, 2026, disclosing the transaction to the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Major investors like BlackRock and Bank of America adjusted their positions in Immunome shares.1 source
Director sold company stock of Immunome, Inc. via SEC filing.1 source
Keep exploring
The entities involved
-
SEC
Slovak company
Related events
- Post Holdings disclosed a stock sale in a legal filing with the Securities and Exchange Commission.
- Patricia Gallup, Chairman of PC Connection, Inc., sold company stock shares and disclosed the transaction to the SEC.
- Lind, a director, sold company stock shares of Lindblad Expeditions and disclosed the transaction to the SEC.
- Director Lisa Jamieson sold shares of Forestar Group stock and disclosed the transaction to the SEC.
- Director Arne Wilhelmsen sold shares of Royal Caribbean Cruises Ltd. and disclosed the transaction to the SEC.